New Danish health care reform can be a barrier for access to Interreg funding of life science innovation

The recently tabled proposal for a new Danish health care reform has many promising elements. However, the idea to let the municipalities take over the responsibility as regards attracting EU/Interreg funding for Danish life science innovation is bad for business and innovation, as MVA CEO Anette Steenberg highlights in her latest piece in Danish “Dagens Medicin”

Most recent news

Engage with us at Folkemødet

Representatives from Medicon Valley Alliance will be attending Folkemødet on Bornholm. This year we will be engaged in several roundtable...